MNV
Market News Video
MNV MNV 10 Stocks Crossing Below Book Value
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

Fulcrum Therapeutics Becomes Oversold (FULC)
Tuesday, August 11, 11:55 AM ET, by Market News Video Staff

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...

The Math Shows IWO Can Go To $258
Wednesday, August 12, 8:12 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Analysts Anticipate 19% Gains Ahead For The Holdings of IWO
Tuesday, September 15, 8:19 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Investors Land FULC Even Cheaper Than Its Secondary Stock Offering
Tuesday, May 4, 11:43 AM ET, by Market News Video Staff

Looking back to 105 days ago, Fulcrum Therapeutics Inc (FULC) priced a 4,000,000 share secondary ...

Investors Land FULC Even Cheaper Than Its Secondary Stock Offering

By Market News Video Staff, Tuesday, May 4, 11:43 AM ET
Play Video: The Importance of ETFs


If the video does not load after a few moments, Upgrade to the Latest Flash Player.

Looking back to 105 days ago, Fulcrum Therapeutics Inc (NASDAQ:FULC) priced a 4,000,000 share secondary stock offering at $11.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time. In trading on Tuesday, bargain hunters could buy shares of FULC and achieve a cost basis 2.6% cheaper than those buyers, with shares changing hands as low as $10.71 per share.

Secondaries can often present buying opportunities for bullish investors interested in purchasing shares, because the sudden extra supply of stock tends to require that the offering be priced at an attractive discount to where the stock had previously been trading before the offering announcement. At last check, Fulcrum Therapeutics Inc shares are currently trading down about 5.5% on the day. The chart below shows the one year performance of FULC shares, versus its 200 day moving average:

Fulcrum Therapeutics Inc Chart

Looking at the chart above, FULC's low point in its 52 week range is $7.01 per share, with $22.39 as the 52 week high point — that compares with a last trade of $10.74.


Special Offer: Join the income investing conversation on ValueForum.com with a special Seven Days for Seven Dollars invitation.


This Article's Word Cloud:   Buyers   Days   Dollars   FULC   Fulcrum   Join   Looking   Offer   Offerings   Recent   Secondaries   Secondary   Seven   Special   Start   Stock   Therapeutics   Tuesday   ValueForum   about   above   achieve   announcement   attractive   average   back   bargain   basis   because   been   before   below   bullish   buyers   buying   changing   chart   cheaper   investment   last   offering   point   priced   share   shares   stock   that   trading   week   with
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy
MNV
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Portfolio Channel Stock Market Definitions
MNV

Investors Land FULC Even Cheaper Than Its Secondary Stock Offering | Market News Video | Copyright © 2008 - 2021, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.